Reallocation of NHS resources may hit the margins of ophthalmology firms providing care on behalf of the public sector.

HealthInvestor sits down with Adam Thorpe, Managing Director and UK head of health at Stax, for a deep dive into the opportunities in UK independent healthcare.

Worries that a crackdown on private provision of SEND care is imminent seem to be overstated.